Diabetes, Vol 38, Issue 10 1271-1274, Copyright © 1989 by American Diabetes Association
Elevated proinsulin in healthy siblings of IDDM patients independent of HLA identity
SG Hartling, F Lindgren, G Dahlqvist, B Persson and C Binder
Steno Memorial Hospital, Gentofte, Denmark.
Based on the recent demonstration of elevated serum proinsulin levels in
cystic fibrosis patients with impaired glucose tolerance, it was
hypothesized that proinsulin could be an indicator of altered beta-cell
function. We therefore analyzed fasting proinsulin levels in 99 siblings of
insulin-dependent diabetes mellitus (IDDM) patients, most of them
discordant for diabetes for greater than 6 yr. The results from this group
were compared with the results from 41 healthy age- and sex-matched control
subjects with no family history of diabetes. Median (range) fasting
proinsulin in siblings was 8.9 pM (1.7-58 pM) vs. 3.8 pM (less than 1.2-28
pM) in control subjects (P less than .00001). There was no difference
between the groups in fasting blood glucose concentrations. Both groups had
fasting insulin concentrations within the normal range with a tendency
toward lower values in the siblings: 108 pM (60-237 pM) vs. 118 pM (71-175
pM) (P = .07). The 99 siblings were subdivided into groups according to HLA
sharing with their diabetic proband. The concentration of proinsulin,
insulin, and blood glucose among the groups of 33 HLA-identical, 40
HLA-haploidentical, and 26 nonidentical siblings did not differ
significantly. The fasting proinsulin level did not correlate with fasting
levels of insulin, blood glucose, age, or body weight. We conclude that
fasting proinsulin is elevated in healthy siblings of IDDM patients,
whereas fasting insulin is normal or slightly decreased independent of HLA
identity with their diabetic sibling. Elevated proinsulin levels could
represent a family trait, perhaps mirroring a beta-cell more vulnerable to
destruction, or it could reflect previous beta-cell damage that does not
lead to IDDM.